Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2025-05-26 12:47 Magnasenses företrädesemission har registrerats – omvandling av betalda tecknade units (BTU) samt första dag för handel med teckningsoptioner av serie TO 5 och TO 6 Regulatory
2025-05-26 12:47 Magnasense’s rights issue has been registered – conversion of paid subscribed units (BTU) and first day of trading in warrants of series TO 5 and TO 6 Regulatory
2025-05-12 23:00 Magnasense announces outcome in rights issue of units Regulatory
2025-05-12 23:00 Magnasense offentliggör utfall i företrädesemission av units Regulatory
2025-05-06 08:30 Magnasense Advances Saliva-Based Diagnostics Breakthrough with Partially Secured, Ongoing Rights Issue – Investors Welcome to Participate Until 8 May 2025
2025-05-05 11:43 Interview with Magnasense: Key Insights from the RADx Initiative
2025-05-01 10:32 Magnasense and Salignostics Successfully Complete Feasibility Study
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.